Search for: "MedImmune, Inc. v. Genentech, Inc" Results 81 - 100 of 121
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Sep 2016, 11:29 am by Dennis Crouch
The leading precedent actual-controversy precedent for patent cases is the Supreme Court’s 2007 decision in MedImmune, Inc. v. [read post]
11 Mar 2015, 9:40 am by Dennis Crouch
MercExchange, L.L.C., 547 U.S. 388 (2006) (injunctive relief) MedImmune, Inc. v. [read post]
3 Mar 2009, 2:43 pm
Genentech,  Inc., 549 U.S. 1163 (2007); and extended the patent exhaustion doctrine in Quanta Computer, Inc. [read post]
21 Jun 2013, 11:41 am by Gene Quinn
The Supreme Court explained the question presented as follows: In Medlmmune, Inc. v. [read post]
8 Mar 2011, 6:33 pm by Dennis Crouch
Teleflex Inc., 550 U.S. 398 (2007) (eliminating technical hurdles for proving an invention obvious and instead applying a "common sense" analysis for assessing patentability); MedImmune, Inc. v. [read post]
13 Dec 2015, 7:55 am by Dennis Crouch
Zimmer, Inc., et al., Supreme Court Docket No. 14-1520 (2015). [3] Octane Fitness v. [read post]
8 Nov 2013, 7:27 am by Ronald Mann
The case follows directly from the Court’s 2007 reversal of the Federal Circuit in MedImmune, Inc. v. [read post]
3 Sep 2008, 10:46 pm
 The court held that the test, previously expanded by the Supreme Court in MedImmune, Inc. v. [read post]